Ryan Murray, ValSource, breaks down far UVC technology, holistic contamination control strategies, and environmental ...

Richard Jaenisch explains how digitally interactive SOPs and Human-AI Training Parallelization help build, measure, and ...

The new pharmaceutical legislation will enter into force in 2026, with the following 2 years serving as a transition period ...

In regard to their presentations at PDA Week 2026, Richard Jaenisch and David Jaenisch discuss balancing AI integration with ...

Malav Parikh, director, Quality Risk Management, Global Quality Compliance and Systems, Takeda, spoke with PharmTech about ...

Ask the Expert Video Series. Welcome to the Ask the Expert video series. This series is an extension of the PharmTech Group’s ...

Quality Risk Management, Global Quality Compliance and Systems, Takeda, spoke with PharmTech about the technologies being ...

On March 25, 2026, Merck, known as MSD outside the United States andCanada, announced it has entered into a definitive ...

Regulatory pressure from GxP, 21 CFR Part 11, and AI/ML guidance elevates requirements for audit trails, data lineage, ...

The pharmaceutical industry is navigating one of its most disruptive periods in recent memory, according to Anthony Lakavage, ...

France’s Saint‑Julien site adds a bioprocess development suite for upstream/downstream scale-up of recombinant proteins, ...

Domestic manufacturing can improve quality oversight by reducing foreign inspection gaps and enabling early FDA engagement ...